23 results
424B3
PBM
Psyence Biomedical Ltd. Warrant
30 Aug 24
Prospectus supplement
4:00pm
of the business. In addition, in many foreign countries, particularly the countries of the European Union, the pricing of prescription drugs is subject … must comply with Health Canada. The regulations in the European Union are similar to those in the U.S. and Canada.
Psyence will focus the phase IIb
F-1
PBM
Psyence Biomedical Ltd. Warrant
19 Aug 24
Registration statement (foreign)
4:07pm
management’s attention away from the operation of the business. In addition, in many foreign countries, particularly the countries of the European Union … and Drugs Act (Canada). Labeling, marketing and selling of any prescription drug must comply with Health Canada. The regulations in the European Union
424B3
PBM
Psyence Biomedical Ltd. Warrant
19 Aug 24
Prospectus supplement
9:27am
the operation of the business. In addition, in many foreign countries, particularly the countries of the European Union, the pricing of prescription drugs … comply with Health Canada. The regulations in the European Union are similar to those in the U.S. and Canada.
Psyence will focus the phase IIb portion
POS AM
PBM
Psyence Biomedical Ltd. Warrant
12 Aug 24
Prospectus update (post-effective amendment)
5:23pm
of the business. In addition, in many foreign countries, particularly the countries of the European Union, the pricing of prescription drugs is subject … . The regulations in the European Union are similar to those in the U.S. and Canada.
Psyence will focus the phase IIb portion of its clinical
F-1/A
u05ggd9vrxbk9g7mq
6 May 24
Registration statement (foreign) (amended)
8:27pm
F-1/A
3zti2
18 Apr 24
Registration statement (foreign) (amended)
6:03am
F-1
zd3ve l9np622
9 Feb 24
Registration statement (foreign)
4:09pm
20-F
EX-4.17
jr0on t61w4bs7bc9h
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.12
dc617wtkbx79n
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.14
5uhf8hjgzvgwz6
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.13
4agbcdkge121mt
31 Jan 24
Annual report (foreign)
5:05pm
20-F
EX-4.4
bh1vkqm hkitdmn3ov
31 Jan 24
Annual report (foreign)
5:05pm
425
EX-10.1
rf0xt04g61pl2nlx
17 Jan 24
Business combination disclosure
6:00am
424B3
cen2y4vmu
15 Nov 23
Prospectus supplement
4:28pm
F-4/A
nyu5c 5l3kne6l23fpjp
13 Nov 23
Registration of securities (foreign) (amended)
3:59pm
F-4/A
7az r0ypmk9q2c7e
13 Nov 23
Registration of securities (foreign) (amended)
9:27am
F-4/A
f8t8 v9ifq
3 Nov 23
Registration of securities (foreign) (amended)
6:17pm
F-4/A
EX-10.2
1as4 ym6cj5avo
3 Nov 23
Registration of securities (foreign) (amended)
6:17pm
F-4/A
EX-10.6
02bdq
3 Nov 23
Registration of securities (foreign) (amended)
6:17pm